Lipella Pharmaceuticals annual return on equity
2022
2023
2024
Lipella Pharmaceuticals Return on Equity (ROE) Growth & History (LIPO)
Lipella Pharmaceuticals's return on equity was −198.12% for fiscal 2024.
View full Lipella Pharmaceuticals company overviewLipella Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −198.12% | −79.99 pp |
| 2023 | 2023-12-31 | −118.13% | −32.95 pp |
| 2022 | 2022-12-31 | −85.18% | — |
Lipella Pharmaceuticals quarterly return on equity
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −59.30% | +32.05 pp |
| Q2 2025 | 2025-06-30 | −38.92% | +5.07 pp |
| Q1 2025 | 2025-03-31 | −43.56% | −1.78 pp |
| Q4 2024 | 2024-12-31 | −85.35% | −59.67 pp |
| Q3 2024 | 2024-09-30 | −91.35% | −41.85 pp |
| Q2 2024 | 2024-06-30 | −43.99% | +0.34 pp |
| Q1 2024 | 2024-03-31 | −41.78% | −16.63 pp |
| Q4 2023 | 2023-12-31 | −25.68% | −13.74 pp |
| Q3 2023 | 2023-09-30 | −49.51% | — |
| Q2 2023 | 2023-06-30 | −44.33% | — |
| Q1 2023 | 2023-03-31 | −25.15% | — |
| Q4 2022 | 2022-12-31 | −11.93% | — |
Lipella Pharmaceuticals return on equity trends
Between the periods ended 2022-12-31 and 2024-12-31, Lipella Pharmaceuticals's return on equity decreased from −85.18% to −198.12%, a change of −112.94 percentage points. The latest reported quarter, Q3 2025, shows −59.30%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lipella Pharmaceuticals source filings ↗